Literature DB >> 6288577

Chromosomes of human hepatoma cell lines.

D Simon, D P Aden, B B Knowles.   

Abstract

The karyotypes of three human hepatoma cell lines Hep G2, Hep 3B and PLC/PRF/5 were investigated by G- and C-banding techniques. In addition to ploidy changes, typical for most carcinoma cell lines, certain markers were found that remained stable throughout passage of these cultures. Chromosome I is involved in multiple translocations, resulting in at least three copies of the chromosome I heterochromatin region in each cell line. Inversion in the 9qh region is also seen. In addition, each of the cell lines consistently contains trisomy of 17q. The rearrangements of chromosome I are most striking in the Hep 3B and PLC/PRF/5 cell lines, which are derived from human hepatocellular carcinomas and contain integrated copies of the hepatitis B viral genome. These two cell lines are characterized by the presence of at least five copies of the I (p13 leads to q21) region that result from multiple deletions and/or translocations; by consistent trisomy and polymorphism of the 9qh region; and by trisomy of chromosome 10 (also involved in rearrangements). The Hep G2 and Hep 3B cell lines behave functionally as highly differentiated liver parenchymal cells and are karyologically distinguishable from PLC/PRF/5 both by the presence of trisomy of 6 (pter leads to q14) and by the finding that one of the homologues of chromosome 15 is 15q+.

Entities:  

Mesh:

Year:  1982        PMID: 6288577     DOI: 10.1002/ijc.2910300106

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Identification of HepG2 variant cell lines by short tandem repeat (STR) analysis.

Authors:  Jos F van Pelt; Ronny Decorte; Paul S H Yap; Johan Fevery
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

2.  Expression and biosynthetic variation of the epidermal growth factor receptor in human hepatocellular carcinoma-derived cell lines.

Authors:  C R Carlin; D Simon; J Mattison; B B Knowles
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

3.  4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor-bearing animals.

Authors:  K Murakami; T Matsuura; M Sano; A Hashimoto; K Yonekura; R Sakukawa; Y Yamada; I Saiki
Journal:  Clin Exp Metastasis       Date:  1998-10       Impact factor: 5.150

4.  Modification of the apolipoprotein B gene in HepG2 cells by gene targeting.

Authors:  R V Farese; L M Flynn; S G Young
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

5.  Trisomy 1 and 8 occur frequently in hepatocellular carcinoma but not in liver cell adenoma and focal nodular hyperplasia. A fluorescence in situ hybridization study.

Authors:  A Nasarek; M Werner; M Nolte; J Klempnauer; A Georgii
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  A new human hepatocellular carcinoma cell line (KYN-1) with a transformation to adenocarcinoma.

Authors:  H Yano; M Kojiro; T Nakashima
Journal:  In Vitro Cell Dev Biol       Date:  1986-11

7.  Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis.

Authors:  S F Ding; N A Habib; J Dooley; C Wood; L Bowles; J D Delhanty
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

8.  Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2.

Authors:  Bo Zhou; Steve S Ho; Stephanie U Greer; Noah Spies; John M Bell; Xianglong Zhang; Xiaowei Zhu; Joseph G Arthur; Seunggyu Byeon; Reenal Pattni; Ishan Saha; Yiling Huang; Giltae Song; Dimitri Perrin; Wing H Wong; Hanlee P Ji; Alexej Abyzov; Alexander E Urban
Journal:  Nucleic Acids Res       Date:  2019-05-07       Impact factor: 16.971

9.  Time course changes of anti- and pro-apoptotic proteins in apigenin-induced genotoxicity.

Authors:  Fotini Papachristou; Ekaterini Chatzaki; Athanasios Petrou; Ioanna Kougioumtzi; Nikolaos Katsikogiannis; Alexandros Papalambros; Grigorios Tripsianis; Constantinos Simopoulos; Alexandra K Tsaroucha
Journal:  Chin Med       Date:  2013-05-04       Impact factor: 5.455

10.  Antiproliferative Activity of Cinnamomum cassia Constituents and Effects of Pifithrin-Alpha on Their Apoptotic Signaling Pathways in Hep G2 Cells.

Authors:  Lean-Teik Ng; Shu-Jing Wu
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-02       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.